Benchmark and data visualization of HK public listed companies in the Diagnostics & Research Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Hong Kong public listed companies in the Diagnostics & Research industry: 3
Hong Kong Diagnostics & Research total companies market cap (USD): $867.8 Million
1-year stock performance comparison (base-100 daily closing prices)
Company | Market Cap (USD) | Country | Sector | Industry |
---|---|---|---|---|
Guangdong Hybribio Biotech Co.,Ltd. | $422.6 M | Hong Kong | Healthcare | Diagnostics & Research |
Global Cord Blood Corporation |
$400.0 M
(Jan. 1, 2023) |
Hong Kong | Healthcare | Diagnostics & Research |
China Biotech Services Holdings Ltd | $45.2 M | Hong Kong | Healthcare | Diagnostics & Research |
Top 1-year algo backtest: +265.99% - Try Disfold DeepFinance for FREE now!